We recognize that no two programs are alike, so our partnering approach adapts to your objectives, providing the right level of access and support to advance your goals.
Work with Adimab’s team to advance your program without the need to build discovery infrastructure internally. Funded discovery is ideal if you want expert Adimab scientists driving antibody discovery and optimization on your behalf.
Within four months of project initiation, we deliver high-quality leads, detailed data packages, and the confidence to make decisions that keep your pipeline moving forward.
Bring Adimab’s technology into your own labs through a structured platform transfer process. We provide the library, protocols, training, and ongoing support your team needs to run discovery and engineering workflows, helping integrate the platform effectively into your R&D environment.
Using our proprietary yeast-based system, you can pursue any target of interest. Our platform transfer partners have initiated more than 230 programs using this approach.
Access validated Adimab modules on a non-exclusive basis to add plug-and-play functionality to your multispecifics programs for maximum flexibility. These outputs, such as our T cell engager components (CD3 and CD28) and heterodimerization solutions, maintain full interoperability with diverse technology platforms and are already trusted by dozens of companies.
Use with funded discovery or license separately to build and test your own solutions.
